Format
Sort by

Send to:

Choose Destination

Search results

Items: 4

1.

Inhaled drugs as risk factors for community-acquired pneumonia.

Almirall J, Bolíbar I, Serra-Prat M, Palomera E, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A; Community-Acquired Pneumonia in Catalan Countries.

Eur Respir J. 2010 Nov;36(5):1080-7. doi: 10.1183/09031936.00022909. Epub 2010 Jun 4.

2.

The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 study.

Ochoa-Gondar O, Vila-Córcoles A, de Diego C, Arija V, Maxenchs M, Grive M, Martin E, Pinyol JL; EVAN-65 Study Group.

BMC Public Health. 2008 Jun 27;8:222. doi: 10.1186/1471-2458-8-222.

3.

Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study.

Ochoa-Gondar O, Vila-Corcoles A, Ansa X, Rodriguez-Blanco T, Salsench E, de Diego C, Raga X, Gomez F, Valdivieso E, Fuentes C, Palacios L; EVAN Study Group.

Vaccine. 2008 Apr 7;26(16):1955-62. doi: 10.1016/j.vaccine.2008.02.021. Epub 2008 Feb 27.

PMID:
18343541
4.

New evidence of risk factors for community-acquired pneumonia: a population-based study.

Almirall J, Bolíbar I, Serra-Prat M, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A; Community-Acquired Pneumonia in Catalan Countries (PACAP) Study Group.

Eur Respir J. 2008 Jun;31(6):1274-84. doi: 10.1183/09031936.00095807. Epub 2008 Jan 23.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk